Compare · FHLT vs OPCH
FHLT vs OPCH
Side-by-side comparison of Future Health ESG Corp. (FHLT) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FHLT and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH carries a market cap of $3.15B.
- OPCH has hit the wire 13 times in the past 4 weeks while FHLT has been quiet.
- OPCH has more recent analyst coverage (15 ratings vs 0 for FHLT).
- Company
- Future Health ESG Corp.
- Option Care Health Inc.
- Price
- $11.38+6.45%
- $20.81+3.69%
- Market cap
- -
- $3.15B
- 1M return
- -
- +1.51%
- 1Y return
- -
- -34.29%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 13
- Recent ratings
- 0
- 15
Future Health ESG Corp.
Future Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest FHLT
- Future Health ESG Corp. filed SEC Form 8-K: Leadership Update
- SEC Form NT 10-Q/A filed by Future Health ESG Corp. (Amendment)
- Future Health ESG Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Polar Asset Management Partners Inc. sold $14,947 worth of shares (1,255 units at $11.91) (SEC Form 4)
- SEC Form NT 10-Q filed by Future Health ESG Corp.
- SEC Form SC 13D filed by Future Health ESG Corp.
- Future Health Esg Associates 1, Llc sold 1,703,486 shares, decreasing direct ownership by 65% to 921,514 units (SEC Form 4)
- Morgan Travis A sold 2,079,245 shares (SEC Form 4)
- Bostic Bradley sold 2,079,245 shares (SEC Form 4)
- SEC Form SC 13G/A filed by Future Health ESG Corp. (Amendment)
Latest OPCH
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)